AHR and pulmonary arterial hypertension: Voelkel NF demonstrated that the cytochrome P450 system (activated by endogenous and exogenous AhR ligands) might control hypoxia, inflammation, angiogenesis, and maybe even quasi-malignant growth, which are hallmarks of the pathobiology of PAH [30, 31].